Recombinant CD38 (Isatuximab Biosimilar) antibody

Catalog No. ABIN7538067

The Human Chimeric anti-CD38 (Isatuximab Biosimilar) antibody is suitable to detect CD38 (Isatuximab Biosimilar) in samples from Human. It has been validated for ELISA and WB.

Quick Overview for Recombinant CD38 (Isatuximab Biosimilar) antibody (ABIN7538067)

Target: CD38 (Isatuximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human, Mouse

Clonality: Chimeric

Conjugate: This CD38 (Isatuximab Biosimilar) antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Grade: Research Grade

Product Details anti-CD38 (Isatuximab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Isatuximab Biosimilar - Anti-CD38 mAb - Research Grade

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Purity: > 85%

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS buffer PH7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for CD38 (Isatuximab Biosimilar)

Target: CD38 (Isatuximab Biosimilar)

Target Type: Biosimilar

Background: Isatuximab is a humanized monoclonal antibody derived from IgG1 that targets CD38, a glycoprotein found on the surface of some immune cells. CD38 is highly expressed by malignant plasma cells in multiple myeloma. Isatuximab is used to treat multiple myeloma.

CAS-No: 1461640-62-9